Dr. Brett E. Fortune, MD, MS

Expert Publications

• Liver transplantation for hepatocellular carcinoma: a surgical perspective.
• Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation.
• Early weight changes after liver transplantation significantly impact patient and graft survival.
• The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
• Why Pursue a Fourth Year in Advanced/Transplant Hepatology?
• Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials.
• Reply to Risk Stratification in Acute Variceal Bleeding: Child-Pugh Versus Model for End-stage Liver Disease.

Media Releases

Triple Board Certified Hepatologist Advancing Patient Care and Clinical Education in the Heart of the Bronx

Bronx, New York – Montefiore Einstein proudly announces the significant contributions of Dr. Brett E. Fortune, an esteemed Medical Director of the Liver Transplant Program. With a distinguished background in hepatology and transplant medicine, Dr. Fortune is dedicated to advancing the care of patients suffering from advanced liver disease and those undergoing liver transplantation. 

Holding an important academic position as an Associate Professor of Medicine in the Division of Hepatology at the Albert Einstein College of Medicine, Dr. Fortune plays a pivotal role in educating and mentoring the next generation of clinicians and researchers. His commitment to teaching and training reflects his belief in the importance of fostering new talent in the field of hepatology.

After earning a Bachelor of Science in Biological Sciences from North Carolina State University in 1999, Dr. Fortune pursued his Doctor of Medicine degree at Wake Forest University School of Medicine, graduating in 2004. He completed his internship and residency in internal medicine at The Ohio State University Wexner Medical Center in 2007, followed by a fellowship in gastroenterology at the University of Colorado Denver, where he also obtained a Master of Science in Clinical Sciences. Dr. Fortune further honed his expertise with a fellowship in transplant hepatology at the said establishment, which he completed in 2012, solidifying his comprehensive knowledge in liver care.

Dr. Fortune’s research endeavors focus on improving clinical outcomes for patients with cirrhosis and portal hypertension and enhancing the quality of care for liver transplant recipients. His significant contributions to the field have led to numerous publications in prestigious peer-reviewed journals and books. In his editorial roles, Dr. Fortune serves as Associate Editor for Liver Transplantation and Liver Section Editor for Digestive Disease Interventions, in addition to his involvement on the editorial board for Hepatology.

Board certified in internal medicine, gastroenterology, and transplant hepatology, Dr. Fortune is recognized as a Diplomate of the American Board of Internal Medicine. His dedication to the field is further demonstrated through his active membership in several professional organizations, including the American Association for the Study of Liver Diseases, the American Gastroenterological Association, and the American Liver Foundation. 

Recognized for his excellence in teaching and mentorship, Dr. Fortune received the Kushlan Junior Faculty Award in 2015 and the Howard M. Spiro Digestive Disease Fellowship Teaching Award in 2016 from Yale School of Medicine. His work continues to inspire both his colleagues and patients alike, reinforcing the commitment of Montefiore Einstein to provide exceptional medical care and education in hepatology. 

Recommended Articles

• Morning Diarrhea: Why Do We Have Diarrhea in the Morning?

  Introduction of Morning DiarrheaOne of the ways the body tries to get rid of any unwanted waste or substance is through diarrhea. This is done by secreting extra fluid to the intestine and thus producing an unusual number of strong contractions of the intestine. This in turn leads to loose or watery...

• Genetic Link Found in Crohn's Disease and Ulcerative Colitis

  nflammatory bowel diseases affect nearly 1.6 million Americans. In individuals who are suffering from IBD, for some reason, the immune system becomes comprised. It mistakes beneficial cells, food, and bacteria for harmful foreign elements. In other instances, the inflammatory response merely will...

• What Are the Signs and Symptoms of Liver Cancer?

  Liver cancer is a condition that is characterized by the abnormal or cancerous growth of liver cells. Liver cells are also called as hepatocytes. Hence, liver cancer can also be called as hepatocellular cancer. Although other cell types can become cancerous, the most common cause of liver cancer is...

• How to Prepare for a Cholecystectomy

  Cholecystectomy is a surgery done to remove the gallbladder. Such procedure is performed as a result of many causes. In most cases, a cholecystectomy is performed to relieve the patient from complications caused by the inflammation of the gallbladder.A gallbladder is an organ that is located just...

• Immunosuppressive Drugs for Crohn's Disease

  Crohn’s disease is an autoimmune disorder. Due to this disorder, the gastrointestinal tract is affected, and the lining of the digestive system is inflamed. Usually, it affects the colon, although it may affect any part. Ulcers, fistulas, or even cracks can develop in the intestine. This can block...

• Pancreatic Cancer: Where is the Pancreas Located in the Body?

  Pancreatic Cancer: Where is the Pancreas Located in the Body?Pancreatic cancer is likely to develop when the cells present in the pancreas multiply uncontrollably forming a cell mass. Do you want to know what is Pancreas? Do you want to know its functions? Do you want to know how it helps your body?...